[Federal Register Volume 85, Number 183 (Monday, September 21, 2020)]
[Notices]
[Pages 59316-59317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20706]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH), 
Subcommittee on Dose Reconstruction Reviews (SDRR), National Institute 
for Occupational Safety and Health (NIOSH); Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Subcommittee for Dose 
Reconstruction Reviews Subcommittee (SDRR) of the Advisory Board on 
Radiation and Worker Health (ABRWH or the Advisory Board). This meeting 
is open to the public, but without a public comment period. The public 
is welcome to submit written comments in advance of the meeting, to the 
contact person below. Written comments received in advance of the 
meeting will be included in the official record of the meeting. The 
public is also welcomed to listen to the meeting by joining the audio 
conference (information below). The audio conference line has 150 ports 
for callers.

DATES: The meeting will be held on November 4, 2020, from 10:30 a.m. to 
4:00 p.m., EST. Written comments must be received on or before October 
28, 2020.

ADDRESSES: You may submit comments by mail to: Sherri Diana, National 
Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS 
C-34, Cincinnati, Ohio 45226.
    Meeting Information: Audio Conference Call via FTS Conferencing. 
The USA toll-free dial-in number is 1-866-659-0537; the pass code is 
9933701.

FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated 
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24, 
Cincinnati, Ohio 45226, Telephone: (513) 533-6800, Toll Free 1(800)CDC-
INFO, Email: [email protected].

SUPPLEMENTARY INFORMATION:
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines that have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule; advice on methods of dose reconstruction, which have 
also been promulgated by HHS as a final rule; advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program; and advice on

[[Page 59317]]

petitions to add classes of workers to the Special Exposure Cohort 
(SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and rechartered under Executive Order 
13889 on March 22, 2020, and will terminate on March 22, 2022.
    Purpose: The Advisory Board is charged with (a) providing advice to 
the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advise the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class. SDRR was 
established to aid the Advisory Board in carrying out its duty to 
advise the Secretary, HHS, on dose reconstruction.
    Matters to be Considered: The agenda will include discussions on 
the following dose reconstruction program quality management and 
assurance activities: Dose reconstruction cases under review from Set 
28, possibly including cases involving, Oak Ridge Gaseous Diffusion 
Plant (K25), Y-12 Plant, and Savannah River Site (SRS) and potentially 
other Department of Energy and Atomic Weapons Employers facilities; 
Dose reconstruction cases under review from Set 25, possibly including 
cases involving, Hooker Electrochemical, Nuclear Metals Inc., West 
Valley Demonstration Project, Carborundum, Metals and Controls Corp and 
potentially other Department of Energy and Atomic Weapons Employers 
facilities; and Dose reconstruction cases under review from Set 27, 
possibly including cases involving, Oak Ridge Gaseous Diffusion Plant 
(K25), Paducah Gaseous Diffusion Plant, SRS and potentially other 
Department of Energy and Atomic Weapons Employers facilities.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-20706 Filed 9-18-20; 8:45 am]
BILLING CODE 4163-18-P